AI Surgical Coaches: Do They Improve Outcomes, or Just Performance Metrics? What Early Real-World Data Show Review Abstract Purpose: This review examines the emerging evidence for artificial intelligence-assisted surgical coaching, with particular emphasis on whether these systems improve clinically meaningful outcomes or primarily improve technical-performance and
Author: Similoluwa Oluwalana
Can Bispecific Antibodies Move Safely Into the Outpatient Clinic? A Label-Concordant Framework for Clinicians
Can Bispecific Antibodies Move Safely Into the Outpatient Clinic? A Label-Concordant Framework for Clinicians Review Abstract Purpose: This review assesses whether CD3-engaging bispecific antibody therapy can be delivered safely in outpatient oncology settings, with emphasis on cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, infection prevention,
Fungal Infections in the ICU: Missed Disease, Colonization, and the Cost of Overcalling Candida
Fungal Infections in the ICU: Missed Disease, Colonization, and the Cost of Overcalling Candida Review Abstract Purpose: This review examines the diagnostic and therapeutic challenges of fungal infections in the intensive care unit, with emphasis on distinguishing missed invasive disease from colonization, biomarker noise, and
Functional Neurological Disorder: From Diagnosis of Exclusion to Rule-In Neurology
Functional Neurological Disorder: From Diagnosis of Exclusion to Rule-In Neurology Review Positive Signs, Diagnostic Safety, and Practical Treatment Pathways for Clinicians Abstract Purpose: This article reviews functional neurological disorder (FND) as a modern rule-in diagnosis, emphasizing positive clinical signs, diagnostic safety, clinician communication, functional seizures,
Cytokine Release Syndrome 2.0: Managing Immune-Effector Toxicity as Cell Therapy Moves Earlier, Broader, and Beyond CAR T
Cytokine Release Syndrome 2.0: Managing Immune-Effector Toxicity as Cell Therapy Moves Earlier, Broader, and Beyond CAR T Review Abstract Purpose: This article reviews cytokine release syndrome (CRS) and related immune-effector toxicities in the expanding era of cellular therapy, with emphasis on practical recognition, risk stratification,
Topical vs Systemic Therapy in Psoriasis: Escalating Wisely in the Biologic Era
Topical vs Systemic Therapy in Psoriasis: Escalating Wisely in the Biologic Era Review Abstract Purpose: This review examines how clinicians should decide among optimized topical therapy, phototherapy, oral systemic treatment, and biologic therapy in plaque psoriasis. Methodology: Review of recent clinical guidelines, FDA prescribing information,
RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection
RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection Review Abstract Purpose: This review examines the evolving role of long-acting respiratory syncytial virus monoclonal antibodies in preventing RSV lower respiratory tract disease in infants and selected young children. Methodology: This article reviews current CDC and
Revisiting Hormone Replacement Therapy: Are the Risks Still Overstated?
Revisiting Hormone Replacement Therapy: Are the Risks Still Overstated? Review Abstract Purpose: This paper reviews whether the risks of menopausal hormone therapy have been overstated in contemporary practice and how clinicians can apply current evidence without minimizing established safety concerns. Methodology: Review of current society
Reducing Low-Value Testing in Family Medicine: High-Yield Diagnostic Stewardship for Common Outpatient Complaints
Reducing Low-Value Testing in Family Medicine: High-Yield Diagnostic Stewardship for Common Outpatient Complaints Review Abstract Low-value diagnostic testing is common in family medicine. These tests can expose patients to false-positive results, incidental findings, and unnecessary treatments. They may also involve radiation, lead to higher costs,
Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient
Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer's Patient Review Abstract Alzheimer's disease is often marked by progressive episodic memory loss, but not all patients start with an amnestic syndrome. Some patients may initially present with issues in visual-spatial skills, language, executive function,
